Tag: Prescription Drugs
Brexanolone Tolerated in Super-Refractory Status Epilepticus
Associated with high rate of third-line agent weaning; no serious adverse events attributed to the drug
Interactions Occur With Cannabidiol, Antiepileptic Drugs
Most observed mean level changes fall within accepted therapeutic range
Osteoporosis Meds Up BMD in Nonmetastatic Prostate Cancer
Review shows improved bone mineral density in men receiving androgen deprivation therapy
mAb Glucagon Receptor Blocker Suitable for Further Development
REGN1193 inhibited glucose increase stimulated by glucagon in dose-dependent manner
Ipragliflozin Beneficial in T2DM Complicated by Liver Disease
Effect similar to pioglitazone, with reduction in body weight, abdominal fat only for ipragliflozin
Genetic Variation Impacts Pharmacokinetics of Exemestane
Significant differences in plasma exemestane area under the curve for OATP1B1 genotype groups
In Utero Psychotropics + Opioids Up Neonatal Drug Withdrawal
Risk of withdrawal increased two-fold with in utero exposure to two or more psychotropics plus opioids
APA: Reasons for Underuse of Buprenorphine by PCPs ID’d
Doctors not willing to increase prescribing due to lack of belief in agonist tx, lack of time for more patients
Canagliflozin Delays Increase in Certain CV Biomarkers in T2DM
Canagliflozin may reduce CV, heart failure risk over two years versus placebo in older patients with T2DM
ABP 501, Adalimumab Biosimilar, Safe and Effective, for Psoriasis
Findings based on comparison over 52 weeks, including single transition
